Navigation Links
Viral Genetics Issues 2010 Year in Review, 2011 Outlook
Date:2/2/2011

SAN MARINO, Calif., Feb. 2, 2011 /PRNewswire/ -- Viral Genetics (Pink Sheets: VRAL) ("the Company") has released its 2010 Year in Review and 2011 Outlook by CEO Haig Keledjian, available on the Company website (www.viralgenetics.com). In 2010 the Company moved closer to its goal of bringing new drugs to market by positioning itself for the significant step of advancing the clinical trial process in 2011. The Company expanded its research facilities and capabilities and is looking forward to gathering data from potential drug therapies using its patented Metabolic Disruption Technology (MDT) and Targeted Peptide Technology (TPT). New data sources include an investigator study of MDT therapies for drug-resistant cancers at Scott and White Hospital this spring, funded in part by a recent $1.5 million anonymous grant to the hospital.

"Progress throughout the past year has brought us closer to fulfilling our mission of bringing new drug therapies to the marketplace," notes Viral Genetics CEO Haig Keledjian in the review. "In 2010 we made concrete, measurable steps towards that goal, while also expanding our research to include the development of biofuel technologies through our new subsidiary, VG Energy. We're well positioned to execute against our business objectives in 2011."

Viral Genetics' patents and proprietary technology are being developed in collaboration with several Texas A&M University researchers and support from the State of Texas. Last year, the Company's lead scientist, Dr. M. Karen Newell Rogers, joined the faculty at Texas A&M University Health Science Center's College of Medicine and the Department of Surgery, Scott and White Hospital in Temple, Texas. Now located in a hospital environment and surrounded by leading clinicians, Dr. Newell Rogers has access to significantly enhanced resources for transiti
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
5. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
6. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
9. BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
10. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
11. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... About implantable medical devices Implantable ... augment, or repair damaged tissues or organs. They ... including cosmetic, spinal, cardiovascular, ophthalmic, and neuro-stimulator implantation ... such as polymers, metals, ceramics, and biologics. ... market to grow at a CAGR of 8.54% ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... is an X-linked disease, which generally affects the ... degeneration and weakness. The disease is caused due ... in the lack of production of dystrophin (a ... individuals. The lack of dystrophin weakens muscle function, ...
Breaking Medicine Technology:Global Implantable Medical Devices Market 2015-2019 2Advanced Wound Dressings - SA Analysis and Market Forecasts 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... HILL, N.C., Nov. 13 Cempra Pharmaceuticals Inc. today announced ... will present at the Lazard Capital Markets 6th Annual Healthcare ... The St. Regis Hotel in New York City. Dr. ... antibiotic clinical programs for the treatment of drug-resistant pathogens including ...
... China, Nov. 13 Niusule Biotech Corp ... NIUS), a leading U.S.-based biotech company focused on developing ... Mr. Ping (Vince) Huang was named the Company,s chief ... Hu, the Company,s chief executive officer, also served as ...
Cached Medicine Technology:Niusule Announces Key Additions to Management Team 2Niusule Announces Key Additions to Management Team 3
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world ... be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof ... 17 at the Olympia London, booth #F33 , Be the first to get a ...
(Date:9/3/2015)... ... , ... Hunters Creek Retrievers is again honored to salute America's ... Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from a premiere ... Christmas with an extra big smile. , This adorable trained Lab Pup is ...
(Date:9/3/2015)... ... September 03, 2015 , ... A scar is an unavoidable result of incision or ... of the body's ability to heal itself. The appearance of a scar is dependent on ... age, genes, and skin pigmentation. ”Many scars fade to near invisibility on their own over ...
(Date:9/3/2015)... MS (PRWEB) , ... September 03, 2015 , ... ... that their team will be participating at the highly anticipated Mississippi Gulf Babypalooza ... expectant mothers coming from all over, from Gulfport, Biloxi, and beyond. We will ...
(Date:9/3/2015)... Rosa, CA (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases of ... One in seven men will be diagnosed with prostate cancer during their lifetime. While only ... to six of every 10 men by age 65, according to the American Cancer ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... increase in adult obesity rates in 31 states during the past ... fatal diseases such as// diabetes, stroke and cancer. ... efforts to curb the overweight epidemic, according to a new report ... titled F as in Fat: How Obesity Policies Are Failing America, ...
... Last year about 22,000 operations were cancelled by 34 hospitals ... to the report from these hospitals thousands of patients had ... be admitted to for elective surgery in 2005 had no ... in Dublin had to cancel 4,281 operations last year. Of ...
... shows that California is the fifth worst in the nation ... ,Texas was the worst with an uninsured ... was uninsured. Minnesota had the best record with only 8.7 ... ,New Mexico was noted to have an uninsured rate of ...
... healthcare problem, which has tickled the curiosity of researchers. To ... numbers of myths doing the rounds. To dispel the myths, ... from time to time. , ,A government ... obesity rates by 2010, where one in five girls between ...
... Papworth Hospital, Cambridge, in 1980 for cardiomyopathy died on Sunday ... heart transplant patient having survived for 26 years after undergoing ... diagnosed with cardiomyopathy and had a heart transplant last year. ... muscle becomes inflamed and does not work properly. ...
... specialists declared yesterday that coughing costs the UK economy ... of productivity when sufferers are not well costs approximately ... , ,According to the British Thoracic Society (BTS), ... asthma, drugs or environment factors. ,The BTS ...
Cached Medicine News:Health News:Rise in Obesity Rates in 31 States 2Health News:Rise in Obesity Rates in 31 States 3Health News:Cancellations of Operations touch 22,000 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: